We are live on
!
Find out more
Kymera Therapeutics
KYMR
KYMR
127 hedge funds and large institutions have $1.15B invested in Kymera Therapeutics in 2022 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 41 increasing their positions, 33 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
270% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 10
34% more call options, than puts
Call options by funds: $2.67M | Put options by funds: $1.99M
27% more funds holding
Funds holding: 100 → 127 (+27)
24% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 33
18% more capital invested
Capital invested by funds: $972M → $1.15B (+$178M)
1.02% more ownership
Funds ownership: 95.55% → 96.56% (+1%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
127
Holders Change
+27
Holders Change %
+27%
% of All Funds
2.19%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
37
Increased
41
Reduced
33
Closed
10
Calls
$2.67M
Puts
$1.99M
Net Calls
+$675K
Net Calls Change
-$2.65M
Top Buyers
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$24M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
+$21M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$14.6M |
| 4 |
AG
Artal Group
Luxembourg
|
+$13.2M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$12.9M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$42.8M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$29.7M |
| 3 |
State Street
Boston,
Massachusetts
|
-$21.9M |
| 4 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$4.32M |
| 5 |
Morgan Stanley
New York
|
-$4.25M |
